Cellosaurus RPMI-7932 (CVCL_2713)

Cell line name RPMI-7932
Synonyms RPMI 7932; RPMI7932; Roswell Park Memorial Institute 7932
Accession CVCL_2713
Resource Identification Initiative To cite this cell line use: RPMI-7932 (RRID:CVCL_2713)
Comments Sequence variation: Has no BRAF mutation (PubMed=15048078).
Sequence variation: Has no NRAS mutation (PubMed=15048078).
Omics: CNV analysis.
Omics: SNP array analysis.
Caution: The exact relationship between HMCB (CVCL_3317) and RPMI-7262/7272/7932/7962/7972 is not clear: all are derived from patient 'Bowes' melanoma.
Disease Melanoma (NCIt: C3224)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children: CVCL_1122 (CHL-1)
Originate from same individual CVCL_3317 ! HMCB
CVCL_T313 ! RPMI-7262
CVCL_T314 ! RPMI-7272
CVCL_T315 ! RPMI-7551
CVCL_T316 ! RPMI-7781
CVCL_T317 ! RPMI-7801
CVCL_T318 ! RPMI-7922
CVCL_T319 ! RPMI-7962
CVCL_T320 ! RPMI-7972
CVCL_T321 ! RPMI-8002
CVCL_T322 ! RPMI-8072
Sex of cell Female
Category Cancer cell line
Publications

DOI=10.1093/jnci/59.2.301
Quinn L.A., Woods L.K., Merrick S.B., Arabasz N.M., Moore G.E.
Cytogenetic analysis of twelve human malignant melanoma cell lines.
J. Natl. Cancer Inst. 59:301-307(1977)

PubMed=327080; DOI=10.1093/jnci/59.1.221
Fogh J., Fogh J.M., Orfeo T.
One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.
J. Natl. Cancer Inst. 59:221-226(1977)

PubMed=833871; DOI=10.1093/jnci/58.2.209
Fogh J., Wright W.C., Loveless J.D.
Absence of HeLa cell contamination in 169 cell lines derived from human tumors.
J. Natl. Cancer Inst. 58:209-214(1977)

PubMed=6277475
Frampton R.J., Suva L.J., Eisman J.A., Findlay D.M., Moore G.E., Moseley J.M., Martin T.J.
Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
Cancer Res. 42:1116-1119(1982)

PubMed=6220172
Dracopoli N.C., Fogh J.
Polymorphic enzyme analysis of cultured human tumor cell lines.
J. Natl. Cancer Inst. 70:469-476(1983)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=9354451
Castellano M., Pollock P.M., Walters M.K., Sparrow L.E., Down L.M., Gabrielli B.G., Parsons P.G., Hayward N.K.
CDKN2A/p16 is inactivated in most melanoma cell lines.
Cancer Res. 57:4868-4875(1997)

PubMed=15048078; DOI=10.1038/sj.onc.1207563
Pavey S., Johansson P., Packer L., Taylor J., Stark M., Pollock P.M., Walker G.J., Boyle G.M., Harper U., Cozzi S.-J., Hansen K., Yudt L., Schmidt C., Hersey P., Ellem K.A.O., O'Rourke M.G.E., Parsons P.G., Meltzer P., Ringner M., Hayward N.K.
Microarray expression profiling in melanoma reveals a BRAF mutation signature.
Oncogene 23:4060-4067(2004)

PubMed=17363583; DOI=10.1158/0008-5472.CAN-06-4152
Stark M., Hayward N.
Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
Cancer Res. 67:2632-2642(2007)

Cross-references
Cell line collections ECACC; 94072246
ICLC; HTL96012
Cell line databases/resources CLDB; cl4180
CLDB; cl4181
Ontologies BTO; BTO:0004062
CLO; CLO_0008872
Gene expression databases GEO; GSM226865
Polymorphism and mutation databases Cosmic; 889039
Cosmic; 928744